医疗设备的销售契约(2016年～2025年)

"医疗器材分销协议" 深入解读并分析了企业如何以及为何签订分销协议。

本报告提供了2016年至2025年分销协议的详细资讯。

本报告提供了双方宣布的分销协议中付款条款的存取权限。这些数据为了解付款条款和交易的其他条款提供了宝贵的见解。

了解潜在合作伙伴协商的交易条款的弹性，有助于深入了解谈判过程，了解在条款谈判中可能出现的情况。虽然许多中小企业会寻求详细的付款条款，但在如何触发付款和权利转让方面，细节决定成败。这种见解并非新闻稿或资料库中的资料，而是可以从合约文件中取得。

本报告提供了自2016年以来公布的分销协议的综合列表，这些协议均记录在“当前协议”“交易和联盟”数据库中，包括可用的财务条款，以及公司及其合作伙伴向美国证券交易委员会提交的实际分销协议文件的在线副本链接。

本报告的第一章介绍了分销交易和业务活动。

第一章对报告进行了介绍，第二章概述并分析了分销趋势，并讨论了各种协议类型的优势。

第三章概述了分销协议的结构。

第四章回顾了自2016年以来的主要分销协议。协议按标题价格列出。如果某项交易已向美国证券交易委员会 (SEC) 公布，则可以透过 "目前协议" "交易和联盟" 资料库的连结在线上存取该协议。

第五章提供了25家最活跃的分销协议製造商的综合清单。每个协议标题都透过 "当前协议" 的 "合约与联盟" 资料库连结到协议记录的全文线上版本，并在可用时连结到实际合约文件，以便轻鬆按需存取每个协议记录。

协议目录包含自 2016 年以来宣布的所有分销协议的完整清单。每个清单都按公司 A-Z、治疗领域和技术类型组织成协议目录。每个协议标题都透过超连结连结到协议记录的线上版本，包括实际合约文件。

该报告还包含大量图表，展示了自 2016 年以来分销协议制定的趋势和活动。

总而言之，本报告为合约製造商提供了有关分销合作协议所需的所有资讯。

主要的优点

医疗器材经销协议为读者提供以下主要优势：

• 了解 2016 年及以后的合约趋势
• 浏览分销协议
• 基准分析 - 确定交易市场价值
• 财务条款
• 按公司 A-Z、治疗领域和技术类型划分的合约目录
• 主要合约
• 最活跃的合约製造商
• 确定每笔交易的资产和交易条款
• 尽职调查 - 评估拟议交易条款是否适合您的合作伙伴
• 节省数百小时的研究时间

调查范围

• 本报告旨在深入了解全球主要生物製药公司的合约趋势和合约结构。

医疗器材分销协议包括：

• 生物製药产业经销协议趋势
• 分销协议结构概述
• 医疗器材分销协议记录目录
• 主要经销协议
• 最活跃的经销协议製造商
• 主要经销合作伙伴

"医疗器材分销协议" 列出了可用的协议。

• 公司 A-Z
• 总价
• 治疗领域
• 技术类型
• 每个协议标题都透过网页连结指向实际的线上协议记录，方便使用者在需要时存取每个协议文件。
• 医疗器材分销协议提供全面的分销协议记录访问，包括可用的协议文件。

分析协议可以进行以下方面的尽职调查：

• 授予或选择哪些权利？
• 合约授予了哪些权利？
• 授予了哪些独占权？
• 合约的付款结构是怎样的？
• 如何审计销售和付款？
• 合约期限是怎样的？
• 合约的关键条款是如何定义的？
• 如何处理并拥有知识产权？
• 谁负责商业化？
• 谁负责开发、供应和製造？
• 如何管理保密和揭露问题？
• 争议如何解决？
• 合约在什么情况下可以终止？
• 如果所有权发生变更会怎样？
• 双方约定了哪些再授权或分包条款？
• 公司需要哪些标准条款？
• 哪些标准条款似乎因合作伙伴或交易类型而异？
• 公司主张哪个契约法管辖区？

目录

摘要整理

第1章 简介

第2章 销售契约趋势

• 简介
• 销售契约定义
• 2016年以后的销售契约趋势
  • 销售契约的各年度转变，2016年～2025年
  • 各开发阶段的销售契约，2016年～2025年
  • 各治疗领域的销售契约，2016年～2025年
  • 各技术类型的销售契约，2016年～2025年
  • 各企业的销售契约，2016年～2025年
• 签订销售联盟契约的理由

第3章 -销售契约结构概要

• 简介
• 销售契约结构

第4章 -主要销售契约

• 简介
• 各金额首位销售契约

第5章 - 最活跃的销售承包商主要25公司

• 简介
• 最活跃的销售承包商主要25公司
• 交易名录
• 交易名录- 各企业(AZ)的销售契约
• 交易名录- 各治疗领域的销售契约
• 交易名录- 各技术类型的销售契约
• 调查关于公司
• 目前联盟
• 目前契约
• Current Partnering的最近的报告标题

Distribution Deals in Medical Devices provides a detailed understanding and analysis of how and why companies enter distribution deals.

Fully revised and updated, the report provides details of distribution deals from 2016 to 2025.

The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of distribution deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in distribution as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of distribution deals.

Chapter 4 provides a review of the leading distribution deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active distribution dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

The deal directory includes a comprehensive listing of all distribution deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in distribution dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about distribution alliances.

Key benefits

Distribution Deals in Medical Devices provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse distribution deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Distribution Deals in Medical Devices is intended to provide the reader with an in-depth understanding of the distribution trends and structure of deals entered into by leading biopharma companies worldwide.

Distribution Deals in Medical Devices includes:

• Trends in distribution dealmaking in the biopharma industry
• Overview of distribution deal structure
• Directory of distribution deal records covering medical devices
• The leading distribution deals by value
• Most active distribution dealmakers
• The leading distribution partnering resources

In Distribution Deals in Medical Devices, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Distribution Deals in Medical Devices provides comprehensive access to available records for distribution deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals since 2016
  • 2.3.1. Distribution dealmaking by year, 2016-2025
  • 2.3.2. Distribution dealmaking by phase of development, 2016-2025
  • 2.3.3. Distribution dealmaking by therapy area, 2016-2025
  • 2.3.4. Distribution dealmaking by technology type, 2016-2025
  • 2.3.5. Distribution dealmaking by most active company, 2016-2025
• 2.4. Reasons for entering into distribution partnering deals

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements, 2016 to 2025
• Figure 3: Distribution deals signed at each phase of development, 2016 to 2025
• Figure 4: Distribution deals by therapy area, 2016 to 2025
• Figure 5: Distribution deals by technology type, 2016 to 2025
• Figure 6: Top 25 most active distribution dealmakers, 2016 to 2025
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value 2016 to 2025
• Figure 11: Most active distribution dealmakers 2016 to 2025